Holen Sie sich die Stockscreener-App
20.02
1.86%
0.365
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Royal Bank of Canada Raises Nurix Therapeutics (NASDAQ:NRIX) Price Target to $27.00 - MarketBeat
Nurix Therapeutics' SWOT analysis: protein degrader stock's potential By Investing.com - Investing.com Australia
Nurix Therapeutics Faces Financial Risks Amid Supreme Court Regulatory Shift - TipRanks
Nurix Therapeutics Reports Solid Progress and Strong Pipeline - TipRanks
Nurix Therapeutics' SWOT analysis: protein degrader stock's potential - Investing.com India
Stifel raises Nurix stock price target to $36, maintains Buy - MSN
JPMorgan Chase & Co. Has Lowered Expectations for Nurix Therapeutics (NASDAQ:NRIX) Stock Price - MarketBeat
HC Wainwright Increases Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00 - MarketBeat
Needham & Company LLC Lowers Nurix Therapeutics (NASDAQ:NRIX) Price Target to $28.00 - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Given New $36.00 Price Target at Stifel Nicolaus - MarketBeat
8 Analysts Have This To Say About Nurix Therapeutics - Benzinga
Nurix Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended November 30, 2024 - Marketscreener.com
Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Nurix Therapeutics Inc. (NRIX) reports earnings - Quartz
Nurix Therapeutics Fiscal Q4 Net Loss Narrows, Revenue Falls -January 28, 2025 at 04:48 pm EST - Marketscreener.com
Nurix Therapeutics (NASDAQ:NRIX) Announces Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update - The Manila Times
Earnings Flash (NRIX) Nurix Therapeutics Reports Q4 Revenue $13.3M, vs. FactSet Est of $14.6M - Marketscreener.com
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update - GlobeNewswire Inc.
(NRIX) Proactive Strategies - Stock Traders Daily
Nurix Therapeutics Inc (NASDAQ: NRIX): Is It Stable And Growing? - Stocks Register
JPMorgan Chase & Co. Increases Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
JPMorgan Chase & Co. Acquires 31,352 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics appoints new chief commercial officer - MSN
Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer - Marketscreener.com
Nurix Therapeutics appoints new chief commercial officer By Investing.com - Investing.com Australia
Nurix Therapeutics Taps Former Ibrutinib Commercial Chief to Lead NX-5948 Launch Strategy - StockTitan
Nurix Therapeutics (NASDAQ:NRIX) Receives "Overweight" Rating from Stephens - MarketBeat
We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth - Yahoo Finance
Learn to Evaluate (NRIX) using the Charts - Stock Traders Daily
Strength Seen in SpringWorks Therapeutics (SWTX): Can Its 6.0% Jump Turn into More Strength? - MSN
Nurix Therapeutics Unveils 2025 Objectives and Achievements - TipRanks
Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases - The Manila Times
Nurix's NX-5948 Cancer Drug Achieves 75% Response Rate, Secures Fast Track Status - StockTitan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 7.1%Time to Sell? - MarketBeat
Nurix Therapeutics: Speculative Bet On BTK Degraders And Targeted Protein Modulation (NASDAQ:NRIX) - Seeking Alpha
Nurix Therapeutics (NASDAQ:NRIX) Trading Up 3.9%What's Next? - MarketBeat
Nurix Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Nurix Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
(NRIX) Trading Report - Stock Traders Daily
Nurix Therapeutics: Still A Cool Story, But This Price Point Remains Too Hot For Me - Seeking Alpha
Nurix therapeutics chief legal officer sells $112k in stock By Investing.com - Investing.com Nigeria
Nurix therapeutics chief legal officer sells $112k in stock - Investing.com India
How the (NRIX) price action is used to our Advantage - Stock Traders Daily
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Has $2.77 Million Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Geode Capital Management LLC Has $32.54 Million Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Barclays PLC Increases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Barclays PLC Buys 56,190 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 3.2%Here's Why - MarketBeat
Jane Street Group LLC Has $3.54 Million Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):